NCT06448624View on ClinicalTrials.gov

Biomarkers & Infection After Prophylactic Antibiotic in Cardiac Implantable Electronic Device Implantation

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions

Heart BlockCIED Related InfectionCIED-related InfectionsAntibiotic ProphylaxisBiomarkers

Interventions

DRUG

Ampicillin sulbactam 3 days

Ampicillin sulbactam 1.5 gram IV BID for 3 days after CIED implantation

DRUG

Placebo 3 days

Placebo for 3 days after CIED implantation

Trial Locations (1)

50244

Kariadi Central General Hospital, Semarang

All Listed Sponsors

collaborator

Dr. Kariadi General Hospital Medical Center

OTHER

lead

Universitas Diponegoro

OTHER

NCT06448624 - Biomarkers & Infection After Prophylactic Antibiotic in Cardiac Implantable Electronic Device Implantation | Biotech Hunter | Biotech Hunter